FDA Label for Serynth Milia Remover Essence
View Indications, Usage & Precautions
Serynth Milia Remover Essence Product Label
The following document was submitted to the FDA by the labeler of this product Jiangxi Hemei Pharmaceutical Co., Ltd. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient
Salicylic acid 1%
Purpose
Milia Remover
Use
For the removal of milia (skin bumps)Aids in exfoliating dead skin cells Helps smooth skin texture
Warnings
For external use only,
Do Not Use
Condition worsens or does not improve within 4 weeks,Severe redness, burning, or swelling occurs.
If pregnant or breast-feeding, ask a health professional before use.
When Using
Avoid contact with eves.lips.and mucous membranes. If contact occurs,rinse thoroughly with water. Do not apply to broken,irritated,or sunburned skin.Excessive drying or peeling may occur.If severe irritation develops,discontinue use.
Stop Use
Condition worsens or does not improve within 4 weeks,Severe redness, burning, or swelling occurs.
If pregnant or breast-feeding, ask a health professional before use.
Ask Doctor
Condition worsens or does not improve within 4 weeks,Severe redness, burning, or swelling occurs.
If pregnant or breast-feeding, ask a health professional before use.
Keep Oot Of Reach Of Children
Keep out of reach of children.
Directions
1.Cleanse and dry the affected skin area thoroughly.2.Apply a thin layer of the product directly onto the milia (skin bumps） once or twice daily, as needed.3.Gently massage until fully absorbed.4.For best results, use consistently for 4 weeks.
Inactive Ingredients
Glycerin, dextrin,xanthan gum,amylopectin, tocopheryl acetate.water.
Principal Display Panel
* Please review the disclaimer below.
